GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

GSK collaborates with LTZ Therapeutics to develop novel myeloid cell engagers for hematologic cancers and solid tumors, focusing on immuno-oncology treatments. The LTZ partnership grants GSK exclusive ...

GSK (GSK) and LTZ Therapeutics have announced a strategic collaboration aimed at developing novel myeloid-cell engager (MCE) therapies in oncology, leveraging LTZ’s proprietary Myeloid Engager ...

Ten days after dropping new album Deadbeat, the Australian psychedelic rock band staged its first proper concert since March 2023. By Eric Renner Brown Tame Impala returned earlier this month with its ...

Should the Chevrolet Impala return as an electric sedan? We imagine how Chevy could revive this American icon for the EV era. The Corvette is Chevy's last remaining traditional car as sedans vanish ...

Vivid Seats is the New York Post's official ticketing partner. We may receive revenue from this partnership for sharing this content and/or when you make a purchase. Featured pricing is subject to ...

On Thursday, Tame Impala announced new album Deadbeat which is out October 17 and just a couple weeks after that they’ll be in the US for a short fall tour, hitting Brooklyn, Chicago, Austin, San ...

Tame Impala has announced his fifth full-length album, “Deadbeat,” due for release on Oct. 17, led by fuzzy singles “End of Summer” and “Loser.” Kevin Parker, the sole member of Tame Impala, released ...

After dropping two songs this summer, Kevin Parker has announced a new Tame Impala album—his first in five years. The follow-up to 2020’s The Slow Rush is titled Deadbeat and arrives October 17 via ...

The last time we got a new Tame Impala song was in 2023 with the Thundercat collaboration “No More Lies,” and there were also features on a couple of Justice songs in 2024. As far as tentpole releases ...